Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 03, 2015 6:18 PM ET

Capital Markets

Company Overview of Enterprise Partners Venture Capital

Company Overview

Enterprise Partners Venture Capital is a venture capital firm specializing in investments in early stage and seed stage companies. It invests in later stage companies and buyout opportunities on a case-by-case basis. The firm typically invests in the healthcare technology, life sciences, and technology sectors with a focus on new technology fields including wireless networks, and specialized energy and materials. It seeks to invest in companies which are located in an around California and Southwest United States. The firm primarily invests between $3 million and $10 million in its portfolio companies and will occasionally invest as little as $300,000 in a seed stage venture. It seeks to tak...

2223 Avenida de la Playa

Suite 300

La Jolla, CA 92037-3218

United States

Founded in 1985

Phone:

858-731-0300

Fax:

858-454-2489

Key Executives for Enterprise Partners Venture Capital

Managing Director
Age: 65
Managing Director
Age: 54
Entrepreneur-In-Residence
Entrepreneur-In-Residence
Compensation as of Fiscal Year 2015.

Enterprise Partners Venture Capital Key Developments

Celladon Corporation Announces In-License of Stem Cell Factor Development Program

Celladon Corporation announced an exclusive, global license from Enterprise Partners Venture Capital for gene therapy applications of the membrane-bound form of the Stem Cell Factor gene (mSCF) for treatment of cardiac ischemia. Stem Cell Factor is a critical cytokine which contributes to cell migration, proliferation, and survival of cardiac stem cells.

Similar Private Companies By Industry

Company Name Region
Duff & Phelps Securities, LLC United States
Swarthmore Associates, LLC United States
Shelby Acquisition I, Inc. United States
Comstock Capital and Advisory Group, LLC United States
Viriathus Research LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Enterprise Partners Venture Capital, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.